Skip to Content

Required screening; facility requirements – Ohio Admin. Code 3701-55-02

Link to the law
This will open in a new window

All newborn children must be screened for the presence of the following genetic, endocrine, or metabolic disorders:

  • Argininemia;
  • Argininosuccinic acidemia;
  • Biotinidase deficiency;
  • Carnitine/acylcarnitine translocase deficiency;
  • Carnitine palmitoyl transferase deficiency type II;
  • Carnitine uptake defect;
  • Citrullinemia;
  • Congenital adrenal hyperplasia;
  • Congenital hypothyroidism;
  • Cystic fibrosis;
  • Galactosemia;
  • Glutaric acidemia type I;
  • Glutaric acidemia type II;
  • Homocystinuria (cystathionine-beta-synthase deficiency);
  • Hypermethioninemia;
  • Isobutyryl-CoA dehydrogenase deficiency;
  • Isovaleric acidemia;
  • Long chain hydroxyacyl-CoA dehydrogenase deficiency;
  • Maple syrup urine disease;
  • Medium chainacyl-CoA dehydrogenase deficiency;
  • Methylmalonic acidemia;
  • Multiple CoA carboxylase deficiency;
  • Phenylketonuria;
  • Propionic acidemia;
  • Short chain acyl-CoA dehydrogenase deficiency;
  • Trifunctional protein deficiency;
  • Tyrosinemia type-I;
  • Tyrosinemia type-II;
  • Tyrosinemia type-III;
  • Very long chain acyl-CoA dehydrogenase deficiency;
  • 2-methylbutyryl-CoA dehyrogenase deficiency;
  • 3-hydroxy-3-methylglutaryl-CoA lyase deficiency;
  • 3-ketothiolase deficiency;
  • 3-methylcrotonyl-CoA carboxylase deficiency; and
  • Sickle cell and other hemoglobinopathies.

Current as of June 2015